<DOC>
	<DOC>NCT02678585</DOC>
	<brief_summary>The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia</brief_summary>
	<brief_title>Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Nalbuphine</mesh_term>
	<criteria>adult patients American Society of Anesthesiologists (ASA) physical status III age between 20 and 50 years old scheduled for elective unilateral short hand surgery allergy to study medications body mass index &gt; 35 kg/m2 patients with sickle cell disease or Reynaud disease patient refusal</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>